Phio Pharmaceuticals Corp (PHIO)

[Inoviorulez]

Scarring anywhere from $2 billion to $5 billion

macular degeneration $3 billion to $4 billion

CNS disorders depends:

If Rxi goes for SMA -- Spinal muscular Atrophy -- $5 billion

if Rxi branches out dermatology to Chronic Wounds $15 billion - $18 billion

It just depends what they choose for the Tyrosinase and collagenese compounds. -- chronic wounds falls under collagenese target if they choose it